{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:51:11Z","timestamp":1791615071392,"version":"4.3.4"},"reference-count":63,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Transplant Infectious Dis"],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>The aim of this study was to evaluate the risk factors for CMV reactivation and the effects of CMV on HSCT outcomes in patients managed using a standard prophylaxis and preemptive treatment approach in settings where letermovir prophylaxis could not be used.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients who underwent HSCT between January 2006 and December 2023 in our pediatric hematology department were included in this retrospective study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 217 patients included, 96 (44.4%) underwent HSCT for malignant diseases. The donor was a matched\u2010sibling for 65.4%, and 86.1% had myeloablative conditioning regimen. All patients received acyclovir prophylaxis (1500\u00a0mg\/m\n                      <jats:sup>2<\/jats:sup>\n                      \/day) for the first 30 days. The prevalences of acute and chronic GVHD were 28.1% and 18%, respectively. In a median (IQR) follow\u2010up of 49 (26.5\u201393.3) months, 60 (27.6%) patients experienced a total of 92 CMV reactivations. Patient group that experienced CMV reactivations was characterized by higher rates of malignant diseases, higher rates of mismatched donors, lower rates of bone marrow as stem cell source, higher acute and chronic GVHD prevalences, and higher grades of acute GVHD. In the group that did not experience CMV reactivation, 2\u2010year overall survival rates were higher and treatment\u2010related mortality rates were lower. This association remained consistent when evaluated among non\u2010malignant patients. However, no significant difference was observed in the malignant diseases.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      After an effective prophylaxis, CMV DNA monitoring combined with preemptive treatment have an important role in CMV management. However, the survival rates among patients experiencing CMV reactivation remain lower.\n                      <jats:boxed-text content-type=\"graphic\" position=\"anchor\">\n                        <jats:graphic xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" mimetype=\"image\/png\" position=\"anchor\" specific-use=\"enlarged-web-image\" xlink:href=\"graphic\/tid70332-gra-0001-m.png\">\n                          <jats:alt-text>image<\/jats:alt-text>\n                        <\/jats:graphic>\n                      <\/jats:boxed-text>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/tid.70332","type":"journal-article","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:41:08Z","timestamp":1791614468000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cytomegalovirus Infections Following Pediatric Hematopoietic Stem Cell Transplantation: An 18\u2010Year Single\u2010Center Experience"],"prefix":"10.1111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2583-8948","authenticated-orcid":false,"given":"Do\u011facan","family":"Sar\u0131soy","sequence":"first","affiliation":[{"name":"Division of Pediatric Rheumatology, Department of Pediatrics Ankara University Faculty of Medicine  Ankara T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"\u00dcnal \u0130nce","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology, Department of Pediatrics Ankara University Faculty of Medicine  Ankara T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilber Talia","family":"\u0130leri","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology, Department of Pediatrics Ankara University Faculty of Medicine  Ankara T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ergin","family":"\u00c7ift\u00e7i","sequence":"additional","affiliation":[{"name":"Division of Pediatric Infectious Diseases, Department of Pediatrics Ankara University Faculty of Medicine  Ankara T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7727-3363","authenticated-orcid":false,"given":"Zeynep Ceren","family":"Karahan","sequence":"additional","affiliation":[{"name":"Department of Microbiology Ankara University Faculty of Medicine  Ankara T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan Fatih","family":"\u00c7akmakl\u0131","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology, Department of Pediatrics Ankara University Faculty of Medicine  Ankara T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4846-5945","authenticated-orcid":false,"given":"G\u00fcl","family":"Arga","sequence":"additional","affiliation":[{"name":"Division of Pediatric Infectious Diseases, Department of Pediatrics Ankara University Faculty of Medicine  Ankara T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3603-4491","authenticated-orcid":false,"given":"Tu\u011fba","family":"Akkaya Hocagil","sequence":"additional","affiliation":[{"name":"Department of Biostatistics Ankara University Faculty of Medicine  Ankara T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candan","family":"\u0130slamo\u011flu","sequence":"additional","affiliation":[{"name":"Division of Pediatric Immunology and Allergy, Department of Pediatrics Ankara University Faculty of Medicine  Ankara T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halil","family":"\u00d6zdemir","sequence":"additional","affiliation":[{"name":"Division of Pediatric Infectious Diseases, Department of Pediatrics Ankara University Faculty of Medicine  Ankara T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Ertem","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology, Department of Pediatrics Ankara University Faculty of Medicine  Ankara T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2034"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2453"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu364"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102003\u201010\u20103616"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352\u20103026(15)00289\u20106"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13627"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2021.10.008"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102013\u201005\u2010499830"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.7.2240"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102015\u201008\u2010663823"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.11.028"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409\u2010018\u20100369\u20100"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2011.05.010"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13096"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102007\u201001\u2010069294"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121\u2010017\u20100180\u2010z"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2024.286082"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1706640"},{"issue":"9","key":"e_1_2_10_20_1","doi-asserted-by":"crossref","first-page":"699.e1","DOI":"10.1016\/j.jtct.2025.05.021","article-title":"Letermovir Primary and Secondary Prophylaxis in Pediatric Recipients of Allogeneic Haematopoietic Stem Cell Transplant","volume":"31","author":"Vendemini F.","year":"2025","journal-title":"Transplantation and Cellular Therapy"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102014\u201002\u2010514778"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.09.001"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705490"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae321"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02571\u201013"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.2991\/chi.d.191207.001"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470\u20102045(15)00197\u20107"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0228451"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399\u20103062.2007.00242.x"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13095"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000014172"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mph.0000174242.80167.9d"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2015.07.011"},{"issue":"21","key":"e_1_2_10_34_1","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.3390\/diagnostics14212461","article-title":"Monitoring and Management of Cytomegalovirus Reactivations After Allogeneic Hematopoietic Stem Cell Transplantation in Children: Experience From a Single Pediatric Center","volume":"14","author":"Ferrando G.","year":"2024","journal-title":"Diagnostics"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409\u2010025\u201002739\u20103"},{"key":"e_1_2_10_36_1","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.3389\/fmicb.2019.01186","article-title":"Human Cytomegalovirus Latency and Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients","volume":"10","author":"Stern L.","year":"2019","journal-title":"Frontiers in Microbiology"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2016.04.004"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102002\u201010\u20103263"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.46989\/001c.131683"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.21037\/tp\u20102025\u2010241"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473\u20103099(25)00069\u20106"},{"key":"e_1_2_10_42_1","unstructured":"Administration USFaD. \"PREVYMIS (Letermovir) Prescribing Information \"U.S. Food and Drug Administration 2025."},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.14251"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.5.3260"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01262\u201006"},{"issue":"4","key":"e_1_2_10_46_1","first-page":"545","article-title":"Investigation of Cytomegalovirus Seroepidemiology in Antalya With a Population\u2010Based Cross\u2010Sectional Study and Review of Related Data in Turkey","volume":"41","author":"Ataman S.","year":"2007","journal-title":"Mikrobiyoloji B\u00fclteni"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1177\/20503121251360132"},{"key":"e_1_2_10_48_1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-3-031-44080-9_14","volume-title":"The EBMT Handbook: Hematopoietic Cell Transplantation and Cellular Therapies","author":"Horgan C.","year":"2024"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2007.06.006"},{"issue":"5","key":"e_1_2_10_50_1","first-page":"462","article-title":"Prophylactic Acyclovir and Preemptive Ganciclovir to Prevent Cytomegalovirus Disease in Children After Hematopoietic Stem Cell Transplant","volume":"12","author":"Tavil B.","year":"2014","journal-title":"Experimental and Clinical Transplantation"},{"issue":"9","key":"e_1_2_10_51_1","first-page":"1290","article-title":"High Incidence of Cytomegalovirus Reactivation in Adult Recipients of an Unrelated Cord Blood Transplant","volume":"90","author":"Takami A.","year":"2005","journal-title":"Haematologica"},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365\u20102141.2003.04264.x"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12288\u2010023\u201001654\u20101"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2015.303"},{"issue":"6","key":"e_1_2_10_55_1","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jtct.2023.03.018","article-title":"Immunologic Monitoring After Allogeneic Stem Cell Transplantation: T\u2010SPOT.CMV and QuantiFERON\u2010CMV, Are They the Same?","volume":"29","author":"Callens R.","year":"2023","journal-title":"Transplantation and Cellular Therapy"},{"key":"e_1_2_10_56_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz1210"},{"issue":"6","key":"e_1_2_10_57_1","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/infdis\/jiy592","article-title":"The Ability of a Cytomegalovirus ELISPOT Assay to Predict Outcome of Low\u2010Level CMV Reactivation in Hematopoietic Cell Transplant Recipients","volume":"219","author":"El Haddad L.","year":"2019","journal-title":"Journal of Infectious Diseases"},{"key":"e_1_2_10_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409\u2010021\u201001394\u20108"},{"key":"e_1_2_10_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.01.018"},{"key":"e_1_2_10_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.09.006"},{"issue":"7","key":"e_1_2_10_61_1","doi-asserted-by":"crossref","first-page":"465 e1","DOI":"10.1016\/j.jtct.2025.04.021","article-title":"Impact of Cytomegalovirus Reactivation Following Allogeneic Hematopoietic Cell Transplantation on the Relapse of Acute Leukemia","volume":"31","author":"Park H.","year":"2025","journal-title":"Transplantation and Cellular Therapy"},{"key":"e_1_2_10_62_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102010\u201008\u2010304121"},{"key":"e_1_2_10_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277\u2010023\u201005509\u20107"},{"key":"e_1_2_10_64_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1032968"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tid.70332","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/tid.70332","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tid.70332","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:41:11Z","timestamp":1791614471000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tid.70332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":63,"alternative-id":["10.1111\/tid.70332"],"URL":"https:\/\/doi.org\/10.1111\/tid.70332","archive":["Portico"],"relation":{},"ISSN":["1398-2273","1399-3062"],"issn-type":[{"value":"1398-2273","type":"print"},{"value":"1399-3062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]},"assertion":[{"value":"2026-07-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70332"}}